ArticleFrontiers in immunology2024

Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma.

Rongce Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.